Zencore Biologics

Shanghai, China (R&D facility: Maryland, USA)
Monoclonal Antibody Recombinant Protein ADC Cell Culture Media Biologics (Drug Substance & Drug Product) Fill-Finish
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (2) ○ EMA GMP ○ MHRA GMP

Quick Facts: Zencore Biologics

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Shanghai, China (R&D facility: Maryland, USA)
Modalities
Monoclonal Antibody, Recombinant Protein, ADC, Cell Culture Media, Biologics (Drug Substance & Drug Product), Fill-Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Zencore Biologics

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Recombinant Protein, ADC, Cell Culture Media, Biologics (Drug Substance & Drug Product), Fill-Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press2 articles
Broad modality coverage (6 modalities)

Recent News 2 articles

news Wed, 10 Ap
Pharmadule Morimatsu completes Zencore Biologics turnkey facility build - Cleanroom Technology
Source →
news Thu, 06 Au
Zencore Biologics & Morimatsu Mo-EAMaster Phase II Project Successfully Completed - Moomoo
Source →

Frequently Asked Questions About Zencore Biologics

What is Zencore Biologics's CDMO Signal Score?
Zencore Biologics has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Zencore Biologics for a manufacturing program?
Use the free AI matchmaker to compare Zencore Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Recombinant Protein CDMOs → ADC CDMOs → Biologics (Drug Substance & Drug Product) CDMOs →

Similar CDMOs

AsymBio
Shanghai, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, ADC, Bioconjugates (NDC, RDC, AOC, PDC, BsADC), Plasmid DNA, mRNA, Fill-Finish
Catalent
Bagsværd, Denmark (operating under Novo Holdings; legacy US operations headquartered in Somerset, NJ)
Signal Score: 76.5
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
Signal Score: 75.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Samsung Biologics
Incheon, South Korea, Rockville, Maryland, USA
Signal Score: 61.5
Monoclonal Antibody, Recombinant Protein, ADC, mRNA, Bispecific Antibody, Antibody Conjugate
Healsun Biopharm (Hangzhou Healsun Biopharm Co., Ltd.)
Hangzhou, China
Monoclonal Antibody, Recombinant Protein, Bispecific Antibody, Fusion Protein, ADC, XDC (ADC, RDC, Bioconjugates), Cell Line Development (CHO)